CHROMAN-DERIVAT

European patent · EP2821404 · In force

Register entry

Publication number
EP2821404
Application number
EP13755532
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 1, 2013
Published
Jan 7, 2015
Granted
Jul 31, 2019
Protection ends at the latest
Feb 28, 2033
Next annual fee due
Mar 31, 2027
IPC classes
C07D 311/58 (2006.01)
C07D 491/052 (2006.01)
C12P 17/06 (2006.01)
Priority
JP 2012046893 02.03.2012
PCT application
PCT/JP2013/055729 01.03.2013
PCT publication
WO2013/129661 06.09.2013
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 22, 2025

    Holder’s address changed

    Owner
    Ji Xing Pharmaceuticals Hong Kong Limited, c/o Ji Xing Pharmaceuticals (Shanghai) Co., Ltd., 22f, JC Plaza, 1225 West Nanjing Road, Jing'an District, Shanghai 200040, China → Corxel Pharmaceuticals Hong Kong Limited, 22f, JC Plaza, 1225 West Nanjing Road, Jing'an District, Shanghai 200040, China

    Published in Swissreg on 22.04.2025

  3. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  4. Jul 18, 2024

    Agent removed

    Owner
    Biogen MA Inc., 225 Binney Street, Cambridge 02142 Massachusetts, USA (removed)
    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano (removed)
    Inventor
    HASEGAWA, Keiko, 32-12-204 Futaba-cho, Itabashi-ku, Tokyo 173-0011, Japan, KITANO, Yoshikazu, 2-40-B-406 Saiwai-cho, Fuchu-shi, Tokyo 183-0054, Japan, SUZUKI, Eriko, 1-31-4-402 Fuchu-cho, Fuchu-shi, Tokyo 183-0055, Japan, NISHIMURA, Yuuichi, 1-8-26-B107 Nishiki-cho,, Fuji-shi,, Shizuoka-ken 417-0045, Japan, TSUJIHARA, Kohta, 921-37 Terao, Kawagoe-shi, Saitama 350-1141, Japan, HASUMI, Keiji, 211-10 Momura, Inagi-shi, Tokyo 206-0804, Japan, NISHIMURA, Naoko, 5-22-9-502 Sekido, Tama-shi, Tokyo 206-0011, Japan (removed)
    Register addresses

    Published in Swissreg on 18.07.2024

  5. Jul 18, 2024

    Transferred

    Register addresses
    Owner
    Ji Xing Pharmaceuticals Hong Kong Limited, c/o Ji Xing Pharmaceuticals (Shanghai) Co., Ltd., 22f, JC Plaza, 1225 West Nanjing Road, Jing'an District, Shanghai 200040, China
    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
    Inventor
    HASEGAWA, Keiko, 32-12-204 Futaba-cho, Itabashi-ku, Tokyo 173-0011, Japan, KITANO, Yoshikazu, 2-40-B-406 Saiwai-cho, Fuchu-shi, Tokyo 183-0054, Japan, SUZUKI, Eriko, 1-31-4-402 Fuchu-cho, Fuchu-shi, Tokyo 183-0055, Japan, NISHIMURA, Yuuichi, 1-8-26-B107 Nishiki-cho,, Fuji-shi,, Shizuoka-ken 417-0045, Japan, TSUJIHARA, Kohta, 921-37 Terao, Kawagoe-shi, Saitama 350-1141, Japan, HASUMI, Keiji, 211-10 Momura, Inagi-shi, Tokyo 206-0804, Japan, NISHIMURA, Naoko, 5-22-9-502 Sekido, Tama-shi, Tokyo 206-0011, Japan

    Published in Swissreg on 18.07.2024

  6. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  7. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  8. Jun 21, 2022

    Transferred

    Owner
    TMS Co. Ltd., 211-10 Momura, Inagi-Shi, Tokyo 206-0804, Japan → Biogen MA Inc., 225 Binney Street, Cambridge 02142 Massachusetts, USA
    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 21.06.2022

2 earlier entries
  1. Jun 15, 2022

    Agent removed

    Representative
    Griffes Consulting SA, 81 route de Florissant, 1206 Genève (removed)

    Published in Swissreg on 15.06.2022

  2. Jul 31, 2019

    Granted

    Published in Swissreg on 31.07.2019

Parties

Inventor

HASEGAWA, Keiko

Tokyo 173-0011, JP

KITANO, Yoshikazu

Fuchu-shi Tokyo 183-0054, JP

SUZUKI, Eriko

Fuchu-shi Tokyo 183-0055, JP

NISHIMURA, Yuuichi

Fuji-shi, Shizuoka-ken 417-0045, JP

TSUJIHARA, Kohta

Kawagoe-shi Saitama 350-1141, JP

HASUMI, Keiji

Inagi-shi Tokyo 206-0804, JP

NISHIMURA, Naoko

Tama-shi Tokyo 206-0011, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.